Wednesday, 23 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Zhaoke Ophthalmology Partners with Somerset Therapeutics to Accelerate US Expansion
CompanyDeals

Zhaoke Ophthalmology Partners with Somerset Therapeutics to Accelerate US Expansion

July 9, 2025
LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth
CompanyDeals

LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth

July 9, 2025
Innovent's Dabote Becomes First China-Originated KRAS G12C Inhibitor Approved in Macau
CompanyDrug

Innovent’s Dabote Becomes First China-Originated KRAS G12C Inhibitor Approved in Macau

July 9, 2025
NK CellTech Secures $14 Million in Series A+++ Financing to Advance NK Cell Therapies
CompanyDeals

NK CellTech Secures $14 Million in Series A+++ Financing to Advance NK Cell Therapies

July 9, 2025
Hengrui Pharmaceuticals Receives NMPA Clearance for SHR-2173 in Primary Membranous Nephropathy
CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Clearance for SHR-2173 in Primary Membranous Nephropathy

July 9, 2025
J&J Submits sNDA to FDA for Caplyta to Prevent Schizophrenia Relapse
CompanyDrug

J&J Submits sNDA to FDA for Caplyta to Prevent Schizophrenia Relapse

July 9, 2025
Novartis' Coartem Baby Approved by Swissmedic for Newborns and Young Infants
CompanyDrug

Novartis’ Coartem Baby Approved by Swissmedic for Newborns and Young Infants

July 9, 2025
Jiangsu Hengrui Gains NMPA Clinical Clearance for HRS-9821 in COPD Treatment
CompanyDrug

Jiangsu Hengrui Gains NMPA Clinical Clearance for HRS-9821 in COPD Treatment

July 9, 2025
NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications
Policy / Regulatory

NMPA Updates Review Procedures for Conditional Drug Marketing Approval Applications

July 9, 2025
Boston Scientific's FARAPULSE Gains FDA Approval for Expanded Use in Persistent Atrial Fibrillation
CompanyMedical Device

Boston Scientific’s FARAPULSE Gains FDA Approval for Expanded Use in Persistent Atrial Fibrillation

July 9, 2025
HutchMed Announces First Commercial Shipments of Tazverik Across China
CompanyDrug

HutchMed Announces First Commercial Shipments of Tazverik Across China

July 9, 2025
Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion
CompanyDeals

Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion

July 8, 2025
1 2 … 15 16 17 18 19 … 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up